Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Mosberg-Galili

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Inflammopharmacology|November 3, 2010
Quo vadis multiple sclerosis?Israel Steiner, Ronit Mosberg-Galili
Journal of the Neurological Sciences|December 11, 2012
Myasthenia gravis in the elderlyMark A Hellmann, Ronit Mosberg-Galili, Israel Steiner
Neuroscience Research|September 27, 2003
Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitisYossi Gilgun-Sherki, Hana Panet, Vered Holdengreber, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Inflammopharmacology|November 3, 2010
Quo vadis multiple sclerosis?Israel Steiner, Ronit Mosberg-Galili
Journal of the Neurological Sciences|December 11, 2012
Myasthenia gravis in the elderlyMark A Hellmann, Ronit Mosberg-Galili, Israel Steiner
Neuroscience Research|September 27, 2003
Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitisYossi Gilgun-Sherki, Hana Panet, Vered Holdengreber, et al.
Pageof 1